HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is …

Oct 24, 2024 · That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients. Our Patient Assistance Programs are intended for people that live in the United …

The ECL assay can detect anti-adalimumab antibody titers independent of adalimumab concentrations in the serum samples. The incidence of anti-adalimumab antibody (AAA) development in patients …

Find and access programs, support and resources for HUMIRA® (adalimumab). See full prescribing information.

Patients treated with HUMIRA are at increased risk for developing serious infections that may lead to hospitalization or death [see Warnings and Precautions (5.1)].

HUMIRA Complete can help patients understand their insurance coverage and assist in identifying ways to save on HUMIRA. Eligible commercially-insured patients can get HUMIRA for as little as $0 a …

May 1, 2024 · Sales of AbbVie 's Humira are plummeting as the once-top-selling drug fights competition from cheaper biosimilars in the U.S. and abroad. But AbbVie has two key drugs that treat many of the...

By entering a phone number, you certify that you are the subscriber/an authorized user for that number and you agree to receive recurring automated, prerecorded, and/or artificial voice calls from “AbbVie” …

Jan 16, 2025 · AbbVie (NYSE: ABBV) has managed to keep its market share for its bestselling arthritis therapy, Humira, above 70%, generic drugmaker Samsung Bioepis said in a new report on Thursday …

AbbVie has been accused of using anti-competitive patent thickets to prevent potentially cheaper biosimilars from entering the market. AbbVie and Alvotech, filed lawsuits against each other …